Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 48, 2014 - Issue 1
Journal homepage
388
Views
21
CrossRef citations to date
0
Altmetric
Review

Diethylstilboestrol for the treatment of prostate cancer: past, present and future

Rafal TuroDepartment of Urology, Stepping Hill Hospital, Stockport NHS Foundation Trust, Stockport, UKCorrespondence[email protected]
,
Michal SmolskiDepartment of Urology, Stepping Hill Hospital, Stockport NHS Foundation Trust, Stockport, UK
,
Rachel EslerDepartment of Urology, Stepping Hill Hospital, Stockport NHS Foundation Trust, Stockport, UK
,
Magda L. KujawaDepartment of Urology, Stepping Hill Hospital, Stockport NHS Foundation Trust, Stockport, UK
,
Stephen J. BromageDepartment of Urology, Stepping Hill Hospital, Stockport NHS Foundation Trust, Stockport, UK
,
Neil OakleyDepartment of Urology, Stepping Hill Hospital, Stockport NHS Foundation Trust, Stockport, UK
,
Adebanji AdeyojuDepartment of Urology, Stepping Hill Hospital, Stockport NHS Foundation Trust, Stockport, UK
,
Stephen C. W. BrownDepartment of Urology, Stepping Hill Hospital, Stockport NHS Foundation Trust, Stockport, UK
,
Richard BroughDepartment of Urology, Stepping Hill Hospital, Stockport NHS Foundation Trust, Stockport, UK
,
Andrew SinclairDepartment of Urology, Stepping Hill Hospital, Stockport NHS Foundation Trust, Stockport, UK
&
Gerald N. CollinsDepartment of Urology, Stepping Hill Hospital, Stockport NHS Foundation Trust, Stockport, UK
 show all
Pages 4-14 | Received 18 Jul 2013, Accepted 22 Oct 2013, Published online: 21 Nov 2013

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Mats J. Stensrud, Jessica G. Young, Vanessa Didelez, James M. Robins & Miguel A. Hernán. (2022) Separable Effects for Causal Inference in the Presence of Competing Events. Journal of the American Statistical Association 117:537, pages 175-183.
Read now
Charles F. Polotti, Christopher J. Kim, Nadiya Chuchvara, Alyssa B. Polotti, Eric A. Singer & Sammy Elsamra. (2017) Androgen deprivation therapy for the treatment of prostate cancer: a focus on pharmacokinetics. Expert Opinion on Drug Metabolism & Toxicology 13:12, pages 1265-1273.
Read now
Antti Kaipia & Harri Visapää. (2017) The complex interplay of sex steroids manifested by endocrine treatment of prostate cancer. Scandinavian Journal of Urology 51:3, pages 206-211.
Read now
Syed I. A. Shah, Paul D. Abel, Trinh Duong, Pat Price & Ruth Langley. (2014) Parenteral oestrogen: Effective and safer than both oral oestrogen and contemporary androgen deprivation therapy for prostate cancer?. Scandinavian Journal of Urology 48:4, pages 411-412.
Read now

Articles from other publishers (17)

Torben Martinussen & Mats Julius Stensrud. (2021) Estimation of separable direct and indirect effects in continuous time. Biometrics 79:1, pages 127-139.
Crossref
Farzad Seidi, Yajie Zhong, Huining Xiao, Yongcan Jin & Daniel Crespy. (2022) Degradable polyprodrugs: design and therapeutic efficiency. Chemical Society Reviews 51:15, pages 6652-6703.
Crossref
Mats J. Stensrud, Miguel A. Hernán, Eric J Tchetgen Tchetgen, James M. Robins, Vanessa Didelez & Jessica G. Young. (2021) A generalized theory of separable effects in competing event settings. Lifetime Data Analysis 27:4, pages 588-631.
Crossref
Herjan J.T. Coelingh Bennink, Jeroen A. van Moorselaar, E. David Crawford, Erik P.M. Roos, Diederik M. Somford, Ton A. Roeleveld, Tjard D. de Haan, Harm H.E. van Melick, Yacov Reisman, Yvette Zimmerman, Gonnie van Osta, Jan Krijgh, Neal D. Shore, Fred Saad, Andrew V. Schally & Frans M.J. Debruyne. (2021) Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi). European Urology Open Science 28, pages 52-61.
Crossref
Tiffani J. Houston & Rita Ghosh. (2020) Untangling the association between environmental endocrine disruptive chemicals and the etiology of male genitourinary cancers. Biochemical Pharmacology 172, pages 113743.
Crossref
Elga Schreiber, Oscar Alfageme, Tania Garcia, Neus González, Juan José Sirvent, Margarita Torrente, Mercedes Gómez & José L. Domingo. (2019) Oral exposure of rats to dienestrol during gestation and lactation: Effects on the reproductive system of male offspring. Food and Chemical Toxicology 128, pages 193-201.
Crossref
James L. MohlerEmmanuel S. AntonarakisAndrew J. ArmstrongAnthony V. D’AmicoBrian J. DavisTanya DorffJames A. EasthamCharles A. EnkeThomas A. FarringtonCelestia S. HiganoEric Mark HorwitzMichael HurwitzJoseph E. IppolitoChristopher J. KaneMichael R. KuettelJoshua M. LangJesse McKenneyGeorge NettoDavid F. PensonElizabeth R. PlimackJulio M. Pow-SangThomas J. PughSylvia RicheyMack RoachStan RosenfeldEdward SchaefferAhmad ShabsighEric J. SmallDaniel E. SprattSandy SrinivasJonathan Tward, Dorothy A. Shead & Deborah A. Freedman-Cass. (2019) Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 17:5, pages 479-505.
Crossref
Ryan W. Dobbs, Neha R. Malhotra, David T. Greenwald, Alice Y. Wang, Gail S. Prins & Michael R. Abern. (2018) Estrogens and prostate cancer. Prostate Cancer and Prostatic Diseases 22:2, pages 185-194.
Crossref
Enrico Radaelli, Sara F Santagostino, Rani S Sellers & Cory F Brayton. (2018) Immune Relevant and Immune Deficient Mice: Options and Opportunities in Translational Research. ILAR Journal 59:3, pages 211-246.
Crossref
Herjan J T Coelingh Bennink, Yvette Zimmerman, Carole Verhoeven, Alice E Dutman, Tjeert Mensinga, Cornelis Kluft, Yacov Reisman & Frans M J Debruyne. (2018) A Dose-Escalating Study With the Fetal Estrogen Estetrol in Healthy Men. The Journal of Clinical Endocrinology & Metabolism 103:9, pages 3239-3249.
Crossref
Darren Ming-Chun Poon, Chi-Kwok Chan, Tim-Wai Chan, Foon-Yiu Cheung, Philip Wai-Kay Kwong, Eric Ka-Chai Lee, Angus Kwong-Chuen Leung, Simon Yiu-Lam Leung, Wai-Kit Ma, Hing-Shing So, Po-Chor Tam & Lap-Yin Ho. (2018) Consensus statements on the management of metastatic prostate cancer from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology. BJU International 121:5, pages 703-715.
Crossref
Payam Moharrami, Perihan Unak, Ozge Kozguş Guldu, E. İ. Medine, Gul Gumuser, Elvan Sayıt Bilgin & Omer Aras. (2017) Multifunctional molecular imaging probes for estrogen receptors: 99mTc labeled diethylstilbestrol (DES) conjugated, cuinp quantum dot nanoparticles (DESCIP). Journal of Radioanalytical and Nuclear Chemistry 314:3, pages 2609-2620.
Crossref
Mikhail V. Pugachev, Thang T. N. Nguyen, Timur M. Bulatov, Roman S. Pavelyev, Alfia G. Iksanova, Oksana V. Bondar, Konstantin V. Balakin & Yurii G. Shtyrlin. (2017) Synthesis and Antitumor Activity of Novel Pyridoxine-Based Bioisosteric Analogs of trans -Stilbenes . Journal of Chemistry 2017, pages 1-7.
Crossref
Leighton Seal. 2017. Genderqueer and Non-Binary Genders. Genderqueer and Non-Binary Genders 183 223 .
Anita Höcherl, Eliézer Jäger, Alessandro Jäger, Martin Hrubý, Rafał Konefał, Olga Janoušková, Jiří Spěváček, Yaming Jiang, Peter W. Schmidt, Timothy P. Lodge & Petr Štěpánek. (2017) One-pot synthesis of reactive oxygen species (ROS)-self-immolative polyoxalate prodrug nanoparticles for hormone dependent cancer therapy with minimized side effects. Polymer Chemistry 8:13, pages 1999-2004.
Crossref
Ruth E. Langley, Howard G. Kynaston, Abdulla A. Alhasso, Trinh Duong, Edgar M. Paez, Gordana Jovic, Christopher D. Scrase, Andrew Robertson, Fay Cafferty, Andrew Welland, Robin Carpenter, Lesley Honeyfield, Richard L. Abel, Michael Stone, Mahesh K.B. Parmar & Paul D. Abel. (2016) A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal Oestradiol. European Urology 69:6, pages 1016-1025.
Crossref
Tetsuya Fujimura, Satoru Takahashi, Haruki Kume, Tomohiko Urano, Kenichi Takayama, Yuta Yamada, Motofumi Suzuki, Hiroshi Fukuhara, Tohru Nakagawa, Satoshi Inoue & Yukio Homma. (2015) Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial. BMC Cancer 15:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.